In July, researchers from the University of North Carolina at Chapel Hill published a study on testosterone heart risks in the medical journal, JAMA Internal Medicine, finding that the side effects of testosterone injections may pose the highest risk of cardiovascular events, hospitalizations and deaths. The team examined the comparative... Read more »

In the August 20, 2015 issue of the New England Journal of Medicine, FDA researchers published an article that expressed their concerns regarding testosterone therapy side effects. Specifically, they are concerned about the use of these products by men who have declining testosterone caused by the natural aging process, rather... Read more »

The use of testosterone replacement therapy (TRT) has been increasing, yet some have expressed concerns about potentially life-threatening side effects of testosterone gels, creams, patches, and other products. Cardiovascular complications are of particular concern. Some men have filed lawsuits against a handful of TRT product manufacturers, claiming that the drugs... Read more »

On August 13, 2015, two New York residents filed an AndroGel lawsuit, alleging that the drug caused a stroke on multiple occasions. The plaintiffs, Denis Sitruk and Suzanne Sitruk, have added their complaint to the multidistrict litigation (MDL) No. 2545, which is proceeding in the U.S. District Court for the... Read more »

The number of product liability complaints regarding testosterone replacement therapy continues to skyrocket, with allegations that the products caused heart attacks, stroke, and debilitating blood clot injuries. Men who took supplements such as Axiron, Testim and Androgel are seeking fair compensation and justice through the legal system, based on counts... Read more »

On July 1, 2015, a West Virginia-based plaintiff filed a personal injury and product liability lawsuit alleging that the drugs AndroGel and Axiron caused the onset of a pulmonary embolism – and the defendants failed to properly warn him of this known risk. The lawsuit was filed within the established multidistrict... Read more »

Over the past several years, the number of testosterone replacement therapy products prescribed to men approaching senior citizen status has literally soared – reaching sales topping $9 billion. The culprit? The apparent onset of the condition known as “low-t,” or low testosterone – a condition believed by some in the... Read more »

District Judge Matthew Kennelly, who is overseeing 1,500 AndroGel testosterone lawsuits in federal court, has denied a request by Abbvie, the manufacturer of AndroGel, to amend the schedule for a group of bellwether trials to be held in 2016 and 2017. Abbvie specifically requested that the court allow expert discovery and summary... Read more »

Testosterone side effects, such as those reported with topical testosterone products like AndroGel, have raised the concern of many healthcare providers and men in recent months. Now, a new study indicates elevated testosterone levels could increase the risk for another complication. The study found a link between high testosterone levels... Read more »

On May 7, 2013, Benjamin B. Reade, Sr. suffered large, bilateral pulmonary emboli and cardiac arrest. He did not survive. The previous day, he had discontinued taking AndroGel, a testosterone replacement therapy product that he had been using since March 20, 2013. On May 7, 2015, his widow, Laura Reade,... Read more »